CWP
XLRN

Concord Wealth Partners’s Acceleron Pharma XLRN Stock Holding History

Concord Wealth Partners’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16
Closed -$3K – 1371
2021
Q3 		$3K Hold
16
– – ﹤0.01% 726
2021
Q2 		$2K Hold
16
– – ﹤0.01% 934
2021
Q1 		$2K Hold
16
– – ﹤0.01% 871
2020
Q4 		$2K Buy
+16
New +$1.88K ﹤0.01% 585

Concord Wealth Partners's XLRN Position: Q4 2021 in Review

Concord Wealth Partners sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 16 shares — an estimated $3K sold.

Concord Wealth Partners first reported a position in XLRN in Q4 2020 and held it in 4 quarters. The position peaked at $3K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Concord Wealth Partners reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Concord Wealth Partners sold 16 Acceleron Pharma shares in Q4 2021, an estimated $3K.
  • Concord Wealth Partners first reported a position in Acceleron Pharma in Q4 2020 and held it in 4 quarters.
  • Concord Wealth Partners's Acceleron Pharma position peaked at $3K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Concord Wealth Partners's 13F filing for Q4 2021, filed 21 Jan 2022.